drugset / Trial / NCT01209845

Ketamine for Low Mood States in the ER

NCT01209845

Phase 1 Completed 14 enrolled Yale University
NaSingle-groupOpen-labelTreatment

Summary

The investigators hope to see if a commonly used drug such as ketamine could help depressed ER patients feel better and improve their mood quickly.

Timeline

Start
2010-04
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.2 mg/kg Intravenous

Indications